Claritev (CTEV) Registration Filing summary

Company overview and business model

• Provides data-driven cost management solutions to the healthcare industry, focusing on transparency, fairness, quality, and affordability.

• Offers services to payors such as health insurers, self-insured employers, government health plans, and third-party administrators, with a national reach.

• Key service lines include analytics-based services, network-based services, payment and revenue integrity, and data and decision science, with pricing models aligned to customer savings or subscription/licensing.

• Expanded internationally into the Middle East and North Africa in 2025 through a strategic partnership, supporting long-term growth.

• Revenue model is primarily performance-based, aligning fees with identified cost savings for clients.

Financial performance and metrics

• Identified $12.5 billion in potential medical cost savings for the six months ended June 30, 2025, $11.9 billion for the same period in 2024, and $24.7 billion for the year ended December 31, 2024.

Use of proceeds and capital allocation

• Net proceeds from securities sales will be used for operations and general corporate purposes, including working capital, with management retaining broad discretion over allocation.

• Pending use, proceeds may be invested in short-term, investment-grade, interest-bearing securities or used to reduce short-term debt.